Tag Archives: VRML

Top Clean Energy Stocks For 2019

What happened 

Solar stocks took a beating Monday after China cut its national incentives to install solar projects. Shares of solar panel manufacturers Canadian Solar Inc. (NASDAQ:CSIQ) fell as much as 14.5%, JinkoSolar Holding Co. (NYSE:JKS) dropped as much as 17%, and Daqo New Energy Corp (NYSE:DQ) fell as much as 31.3% while inverter manufacturer Enphase Energy Inc (NASDAQ:ENPH) fell up to 13.5%. By early afternoon, most major stocks in the solar industry were down double digits.

So what

There were two pieces of China’s solar ruling, one having to do with distributed generation (DG) and the other with utility-scale solar.

Image source: Getty Images.

On the DG side, China put a cap of 10 gigawatts (GW) for new solar projects in 2018, down from 19 GW installed in 2017. According to Asia Europe Clean Energy Advisory Co (AECEA), there may already be more than 10 GW of DG projects installed in China, so that could make it tough to build any projects in the second half of the year.

Top Clean Energy Stocks For 2019: NextEra Energy, Inc.(NEE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Argent Trust Co lifted its holdings in shares of NextEra Energy Inc (NYSE:NEE) by 67.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,148 shares of the utilities provider’s stock after buying an additional 12,598 shares during the period. Argent Trust Co’s holdings in NextEra Energy were worth $5,414,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on NextEra Energy (NEE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By Shane Hupp]

    Shares of NextEra Energy Inc (NYSE:NEE) have been given an average recommendation of “Buy” by the fourteen analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $178.75.

  • [By Joseph Griffin]

    Wendell David Associates Inc. raised its stake in NextEra Energy Inc (NYSE:NEE) by 1.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 54,474 shares of the utilities provider’s stock after acquiring an additional 760 shares during the period. NextEra Energy accounts for about 1.4% of Wendell David Associates Inc.’s investment portfolio, making the stock its 20th biggest holding. Wendell David Associates Inc.’s holdings in NextEra Energy were worth $9,130,000 as of its most recent filing with the Securities & Exchange Commission.

Top Clean Energy Stocks For 2019: TriMas Corporation(TRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    TriMas (NASDAQ: TRS) and Shiloh Industries (NASDAQ:SHLO) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, institutional ownership and earnings.

  • [By Max Byerly]

    Liberum Capital reissued their buy rating on shares of Tarsus Group (LON:TRS) in a research report released on Friday.

    A number of other analysts have also commented on the company. Peel Hunt reaffirmed a buy rating on shares of Tarsus Group in a research report on Friday, June 29th. Deutsche Bank initiated coverage on Tarsus Group in a report on Tuesday, June 26th. They set a buy rating and a GBX 360 ($4.69) price objective for the company. Finally, Numis Securities reissued a buy rating on shares of Tarsus Group in a report on Thursday, July 26th.

  • [By Ethan Ryder]

    Shares of TriMas Co. (NASDAQ:TRS) hit a new 52-week high and low during trading on Monday . The company traded as low as $28.95 and last traded at $28.20, with a volume of 1202 shares trading hands. The stock had previously closed at $28.60.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on TriMas (TRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    TriMas (NASDAQ:TRS) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

Top Clean Energy Stocks For 2019: Rigel Pharmaceuticals Inc.(RIGL)

Advisors’ Opinion:

  • [By Trey Thoelcke]

    Here too, the low price makes this stock an attractive target. Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) is engaged in the discovering, developing and providing novel small molecule drugs that improve the lives of patients with immune and hematological disorders, cancer and rare diseases.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Rigel Pharmaceuticals (RIGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Dan Caplinger]

    Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven’t seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here’s why they did so well.

  • [By Cory Renauer]

    Here’s why analysts are willing to stick their necks out and predict huge gains ahead for these fledgling drugmakers. Just remember, huge potential rewards usually come with a great deal of risk.

    Company (Symbol) Bank Recent Price Target Implied Upside at Recent Prices
    Tocagen Inc. (NASDAQ:TOCA) Citigroup $27 141%
    Vital Therapies, Inc. (NASDAQ:VTL) Cantor Fitzgerald $18 142%
    Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Citigroup $8.50

    156%

Top Clean Energy Stocks For 2019: Woori Bank(WF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Woori Bank (NYSE:WF) and ANZ (OTCMKTS:ANZBY) are both large-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Wells Fargo (WF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    News headlines about Woori Bank (NYSE:WF) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Woori Bank earned a news sentiment score of 0.19 on Accern’s scale. Accern also assigned press coverage about the bank an impact score of 46.2147954877183 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Top Clean Energy Stocks For 2019: Vermillion, Inc.(VRML)

Advisors’ Opinion:

  • [By Max Byerly]

    Vermillion, Inc. (NASDAQ:VRML) CFO Robert Harry Beechey acquired 75,000 shares of the company’s stock in a transaction that occurred on Thursday, August 23rd. The shares were acquired at an average cost of $0.61 per share, for a total transaction of $45,750.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Stephan Byrd]

    Media headlines about Vermillion (NASDAQ:VRML) have been trending somewhat positive this week, Accern reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Vermillion earned a coverage optimism score of 0.03 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.6924212135165 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Joseph Griffin]

    Vermillion (NASDAQ: VRML) and Myriad Genetics (NASDAQ:MYGN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

  • [By Benzinga News Desk]

    Shari Redstone is one “disloyal” media heiress, according to CBS (NYSE: CBS): Link

    ECONOMIC DATA
    US Initial Jobless Claims for May 18 234.0K vs 220.0K Est; Prior 222.0K. US Continuing Claims for May 11 1.74M vs 1.75M Est; Prior 1.71M
    Existing home sales report for April will be released at 10:00 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks in underground storage is schedule for release at 10:30 a.m. ET.
    Atlanta Fed President Raphael Bostic will speak at 10:35 a.m. ET.
    The Treasury is set to auction 7-year notes at 1:00 p.m. ET.
    The Kansas City Fed manufacturing index for May will be released at 11:00 a.m. ET.
    Philadelphia Federal Reserve Bank President Patrick Harker is set to speak at 2:00 p.m. ET.
    Data on money supply for the latest week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    UBS upgrades Deere (NYSE: DE) from Neutral to Buy
    Wells Fargo upgrades Oceaneering (NYSE: OII) from Market Perform to Outperform
    Canaccord downgrades Vermillion (NASDAQ: VRML) from Buy to Hold
    Wedbush downgrades Karyopharm Therapeutics (NASDAQ: KPTI) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

Top Clean Energy Stocks For 2019: Basilea Pharmaceutica Ltd. (BPMUF)

Advisors’ Opinion:

  • [By ]

    Basilea Pharmaceuticals (OTC:BPMUF)

    BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called “tumor checkpoint controller” inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Basilea Pharmaceutica (BPMUF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Blue Chip Stocks To Own Right Now

Sports and stocks go hand in hand.

Wall Street denizens often talk about slam dunk investments and describe the economic cycle as being in a particular inning.

So it makes perfect sense that there’s an ETF dedicated to the business of sports.

The ProSports Sponsors exchange-traded fund, which has the ticker symbol FANZ (FANZ), invests in companies that have business deals with the four major US team sports leagues.

Nick Fullerton, CEO of SportsETFs, the company behind the fund, said it was set up last year to take advantage of the popularity of team sports, which bring in big dollars.

Legal gambling, which is set to spread across the United States, could boost that popularity even more.

Fullerton was quick to point out that the companies in the FANZ ETF must have an actual sponsorship with a major league, and not just a naming rights deal on a stadium.

No CMGIs or Enrons here.

“These are blue chip companies with strong balance sheets and cash flow,” Fullerton said.

Top 5 Blue Chip Stocks To Own Right Now: Vermillion, Inc.(VRML)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Vermillion (NASDAQ: VRML) and Myriad Genetics (NASDAQ:MYGN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

  • [By Logan Wallace]

    Vermillion, Inc. (NASDAQ:VRML) CFO Robert Harry Beechey bought 100,000 shares of Vermillion stock in a transaction dated Tuesday, August 14th. The stock was acquired at an average cost of $0.52 per share, for a total transaction of $52,000.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

  • [By Benzinga News Desk]

    Shari Redstone is one “disloyal” media heiress, according to CBS (NYSE: CBS): Link

    ECONOMIC DATA
    US Initial Jobless Claims for May 18 234.0K vs 220.0K Est; Prior 222.0K. US Continuing Claims for May 11 1.74M vs 1.75M Est; Prior 1.71M
    Existing home sales report for April will be released at 10:00 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks in underground storage is schedule for release at 10:30 a.m. ET.
    Atlanta Fed President Raphael Bostic will speak at 10:35 a.m. ET.
    The Treasury is set to auction 7-year notes at 1:00 p.m. ET.
    The Kansas City Fed manufacturing index for May will be released at 11:00 a.m. ET.
    Philadelphia Federal Reserve Bank President Patrick Harker is set to speak at 2:00 p.m. ET.
    Data on money supply for the latest week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    UBS upgrades Deere (NYSE: DE) from Neutral to Buy
    Wells Fargo upgrades Oceaneering (NYSE: OII) from Market Perform to Outperform
    Canaccord downgrades Vermillion (NASDAQ: VRML) from Buy to Hold
    Wedbush downgrades Karyopharm Therapeutics (NASDAQ: KPTI) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Max Byerly]

    Vermillion, Inc. (NASDAQ:VRML) CFO Robert Harry Beechey acquired 75,000 shares of the company’s stock in a transaction that occurred on Thursday, August 23rd. The shares were acquired at an average cost of $0.61 per share, for a total transaction of $45,750.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Stephan Byrd]

    Media headlines about Vermillion (NASDAQ:VRML) have been trending somewhat positive this week, Accern reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Vermillion earned a coverage optimism score of 0.03 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.6924212135165 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 5 Blue Chip Stocks To Own Right Now: BWX Technologies, Inc.(BWXT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BWX Technologies (BWXT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on BWX Technologies (BWXT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    News coverage about BWX Technologies (NYSE:BWXT) has trended somewhat positive on Friday, Accern reports. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. BWX Technologies earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 44.8987761555585 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Stephan Byrd]

    Synovus Financial Corp acquired a new stake in shares of BWX Technologies (NYSE:BWXT) during the first quarter, Holdings Channel reports. The fund acquired 1,892 shares of the technology company’s stock, valued at approximately $122,000.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on BWX Technologies (BWXT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Blue Chip Stocks To Own Right Now: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Chris Hill]

    Next up, the Justice Department has formally charged Huawei with a list of crimes that include stealing trade secrets from T-Mobile (NASDAQ:TMUS) as well as bank and wire fraud. And while China will have the telecom and smartphone giant’s back, there’s probably no way this ends well. Finally, after last week’s Brumadinho dam disaster, which spilled 3 million gallons of contaminated mining waste, destroyed a town, and killed at least 65 people in Brazil, Vale (NYSE:VALE) shareholders have to be asking themselves if the company is doomed.

  • [By Daniel B. Kline]

    Give Sprint (NYSE:S) CEO Marcelo Claure credit for stopping the bleeding. His efforts have at least stopped his company’s steady decline in a highly competitive battle with low-price rival T-Mobile (NASDAQ:TMUS), as well as bigger players Verizon (NYSE:VZ) and AT&T (NYSE:T).

  • [By ]

    After years of on-again, off-again talks, Sprint (S) and T-Mobile (TMUS)  finally announced a merger Sunday.

    Sprint investors will receive 0.10256 shares of T-Mobile for each share of Sprint. Based on T-Mobile’s close at $64.52 on Friday, the deal values Sprint at $6.62 per share. Including assumed debt, the deal values Sprint at about $59 billion.

Top 5 Blue Chip Stocks To Own Right Now: Taiwan Semiconductor Manufacturing Company Ltd.(TSM)

Advisors’ Opinion:

  • [By Anders Bylund]

    Cryptocurrency mining is no longer the leading theme in AMD’s analyst reports. Instead, Wall Street’s finest are focusing on AMD’s solid Ryzen and EPYC brands taking market share from Intel (NASDAQ:INTC) in both the server systems and gaming rig markets. On top of AMD’s sharp execution in recent quarters, Intel appears to have fumbled the manufacturing technology lead to the point where AMD can lean on foundry partner Taiwan Semiconductor Manufacturing (NYSE:TSM) to deliver seven-nanometer chip architectures while Intel’s in-house manufacturing lines are stuck at 10 nm.

  • [By Anders Bylund, Chris Neiger, and Ashraf Eassa]

    We asked a handful of your fellow tech investors here at The Motley Fool what they see as the best tech investments in early May. Read on to see why our panelists recommend Taiwan Semiconductor Manufacturing (NYSE:TSM), PayPal (NASDAQ:PYPL), and Crown Castle International (NYSE:CCI) at this moment in time.

  • [By Ashraf Eassa]

    Contract chip manufacturing giant Taiwan Semiconductor Manufacturing Company (NYSE:TSM) recently announced that for 2018, it expects to boost its capital expenditure budget to between $11.5 billion and $12 billion, up from a prior range of $10.5 billion to $11 billion. 

  • [By ]

    The capex budget – In January, Intel set a 2018 capital spending budget of $13.5 billion to $14.5 billion, which was easily above 2017 capex of $11.8 billion. Will the budget be tweaked? Last week, Taiwan Semiconductor (TSM) , the world’s biggest chip foundry, upped its 2018 capex budget by $1 billion to a range of $11.5 billion to $12 billion.

  • [By Ashraf Eassa]

    But there are companies similar to Intel — that is, large-cap chip companies that dominate in their respective fields — that I think are worth considering more closely: Broadcom (NASDAQ:AVGO), Taiwan Semiconductor Manufacturing Company (NYSE:TSM), and Micron (NASDAQ:MU).

  • [By Ashraf Eassa]

    Taiwan Semiconductor Manufacturing Company (NYSE:TSM), or TSMC for short, is one of Apple’s (NASDAQ:AAPL) most important suppliers. The company has manufactured Apple’s A-series chips starting with the A8 and continuing through to today’s A12 Bionic chip and has been the exclusive manufacturer of all but one of those chips — the A9.

Top 5 Blue Chip Stocks To Own Right Now: Prothena Corporation plc(PRTA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Prothena Corporation plc (NASDAQ: PRTA) shares dropped 69 percent to $11.43 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction. Unfortunately, there were no statistically significant difference between the two treatment groups.

  • [By Chris Lange]

    Prothena Corp. PLC (NASDAQ: PRTA) shares hit a multiyear low on Monday, one not seen since 2013. This came on the heels of news that the company would be discontinuing development of NEOD001, an investigational antibody that was being evaluated for the treatment of AL amyloidosis.

  • [By Brian Feroldi]

    In response to announcing that it is stopping all clinical development of its lead product candidate, Prothena (NASDAQ:PRTA), a clinical-stage biotech focused on neuroscience and orphan diseases, saw its shares fall 69% as of 11 a.m. EDT.

  • [By Jon C. Ogg]

    Creating a treatment for a rare disease or rare disorder can come with massive upside if the treatment is successful. That said, the risk is that a company can implode if its rare disease treatment fails in a drug study. Now it looks as if Prothena Corporation plc (NASDAQ: PRTA) is on the verge of implosion based upon how its stock price reacted.

  • [By Lisa Levin]

    Prothena Corporation plc (NASDAQ: PRTA) shares dropped 68 percent to $11.79 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction. Unfortunately, there were no statistically significant difference between the two treatment groups.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

stock trading tutorial

Pick and Shovel Play

During the California Gold Rush from 1848 to 1855, nearly 300,00 people migrated to California in hopes of hitting the gold jackpot. Most spent their savings chasing dreams in the high-risk mining operations and went bankrupt. One business man, however, became California’s first millionaires. He hyped the goldrush in his newspaper, the California Star, before profiting by selling picks and shovels to overeager dreamers.

History tends to repeat itself.

Fast forward today, and a craze has broken out over Bitcoin. Every hour a new article comes out projected Bitcoins meteoric rise. Some have even started noticing the energy consumption required to mine a bitcoin on a global level as trading volumes have increased. This has setup a perfect opportunity to capitalize on the Bitcoin frenzy by mining the miners – investing in the exchanges that charge fees for every Bitcoin trade.

The Company

Cboe Global Markets Inc. (CBOE) will become the first futures exchange for the crypto currency. While theres plenty of value to being first to market (separate discussion), Ill focus on the current valuation of CBOEs current stock price using a discounted cash flow model.

stock trading tutorial: Marathon Petroleum Corporation(MPC)

Advisors’ Opinion:

  • [By Stephen Mack]

    We’ve seen this happen before. In December, shares of Russian oil company Rosneft jumped 21% in two weeks when it was acquired by Glencore Plc. (LON: GLEN). And back in 2015, MarkWest Energy Partners LP (NYSE: MWE) enjoyed a similar jump when it was acquired by Marathon Petroleum Corp (NYSE: MPC).

  • [By WWW.MONEYSHOW.COM]

    Marathon Petroleum Corporation (MPC) is an American petroleum refining, marketing, and transportation company headquartered in Findlay, Ohio, explains dividend reinvestment expert Vita Nelson, editor of DirectInvesting.

stock trading tutorial: Vermillion, Inc.(VRML)

Advisors’ Opinion:

  • [By Alex McGuire]

    Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…

    Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%

    The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.

stock trading tutorial: Access National Corporation(ANCX)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, ourunder the Radar Moversnewsletter suggestedshorting small cap Northern Virginia based bank holding stock Access National Corporation (NASDAQ: ANCX):

stock trading tutorial: Polo Ralph Lauren Corporation(RL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The sidewalks outside stores like Armani, Dolce & Gabanna, Ralph Lauren (RL) , Gap (GPS) , Prada, Abercrombie & Fitch (AF) , Microsoft (MSFT) and Harry Winston are now lined with metal barricades. The strip commands some of the highest retail rents in the world, with the average annual rent being $3500 per square foot.

  • [By Casey Wilson]

    Amazon has been a growing pain in the neck for low-price retailers like Wal-Mart Stores Inc. (NYSE:WMT) for some time, but even high-end specialty stores like Ralph Lauren Corp. (NYSE: RL) have struggled now that Amazon has crept into their sector.

  • [By Casey Wilson]

    Ralph Lauren Corp. (NYSE: RL) just became the latest company to fall victim to the “Retail Ice Age.”

    The 50-year-old American icon announced it shuttered its flagship store at Fifth Avenue and 55th Street in New York City on Tuesday (April 4). It will also close 50 other retail locations by the end of the fiscal year.

  • [By Johanna Bennett]

    Times are tough for Ralph Lauren (RL). Profit and sales are fallingat theiconic clothingcompany, and investors who bet on a turnaround havelost their shirts on the stock. Adding to its troubles,CEO StefanLarsson is departingfollowing a creative clash with the companys namesake and founder.

    Pessimism, meanwhile, appears to be on the rise.

    According to a report by the financial analytics company S3 Partners, short interest in Ralph Lauren has risen since the start of the year, hitting historical levels. And while that short position is expected to keep expanding, bearish sentiments could turn on a dime.

    Ihor Dusaniwsky at S3 Partners writes:

    RL short interest levels, already at historical highs today, should continue to grow if the recent trend continues, but having made almost 23% in 2016 and 14% in 2017, short sellers may be quick to cover their positions and lock in profits if RLs stock price turns against them.

    Short interest in Ralph Lauren fell in 2016 as the stock price fella nd shorts covered positions, netting a return of 22.6%. So far this year, however, the short position as increased $226 million, or 38% to $815 million as of this morning, according to the S3 report.

    Its a profitable day for those short sellers. Todays 11% decline Ralph Laurens stock price on an $815 million short position has added $90 million to the short sellers collective bottom line.

    Ralph Lauren is down 11.5% in recent market actions to $77.26 a after earlier falling as low as $76.86 a share. Thats the lowest price for the stock since 2010.

  • [By Ben Levisohn]

    Hanesbrands was just one of many retail companies that got shellacked this week. Under Armour (UAA) tumbled 29% after missing earnings forecasts and cutting its guidance, while Deckers Outdoor (DECK) plunged 21% after its earnings missed the Street consensus, and Ralph Lauren (RL) plummeted 13% after its CEO stepped down.

stock trading tutorial: Xenon Pharmaceuticals Inc.(XENE)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggestedgoing long on small cap orphan biopharmaceutical stock Xenon Pharmaceuticals (NASDAQ: XENE):

  • [By Lisa Levin]

    Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares dropped 53 percent to $4.68 after the company disclosed that XEN801 did not meet efficacy endpoints in Phase 2 trial.

  • [By Jim Robertson]

    Yesterday, our Under the Radar Moversnewsletter suggested going long on small cap biopharmaceutical stock Xenon Pharmaceuticals Inc (NASDAQ: XENE):

  • [By Lisa Levin]

    Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares dropped 51 percent to $4.80 after the company disclosed that XEN801 did not meet efficacy endpoints in Phase 2 trial.

day trading penny stocks

15 Most Overlooked Tax Deductions: 2017

For Fiduciary Rule, Morningstar Sees Up to $150M in Annual Class Action Settlements

Top 10 Cities for Millennial Homebuyers

Wells Fargo & Co. said credit-card applications dropped 55 percent in February from a year earlier, the biggest decline since a scandal involving fake accounts erupted in September.

Retail customers opened 43 percent fewer checking accounts in February, marking the sixth straight month of declines since regulators fined the bank over the creation of unauthorized accounts.

Copyright 2017 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

The service, to be called Intuitive Investor, aims to bring in new, younger clients to its wealth management unit.

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources 5 Steps to Eradicate Text Messaging Risk

In this White Paper, we share five steps to help you build a risk management program that enables the benefits of text messaging while protecting…

day trading penny stocks: BioLineRx Ltd.(BLRX)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biopharmaceutical stockBioline RX Ltd (NASDAQ: BLRX) as a speculative buy:

  • [By William Romov]

    Currently trading at $1.09 per share, BioLine Rx Ltd. (Nasdaq: BLRX) develops a broad range of drug candidates to treat cancer, liver fibrosis, and even dry eye syndrome.

day trading penny stocks: Vermillion, Inc.(VRML)

Advisors’ Opinion:

  • [By Alex McGuire]

    Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…

    Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%

    The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.

day trading penny stocks: Bill Barrett Corporation(BBG)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Petroleo Brasileiro S.A.- Petrobras (NYSE: PBR): Free Stock Analysis Report
     
    Bill Barrett Corporation (NYSE: BBG): Free Stock Analysis Report
     
    Northern Oil and Gas, Inc. (AMEX:NOG): Free Stock Analysis Report
     
    Rice Midstream Partners LP (NYSE: RMP): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Canadian Natural Resources Limited (NYSE: CNQ): Free Stock Analysis Report
     
    Cenovus Energy Inc (NYSE: CVE): Free Stock Analysis Report
     
    Bill Barrett Corporation (NYSE: BBG): Free Stock Analysis Report
     
    ConocoPhillips (NYSE: COP): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

  • [By Lisa Levin]

    On Thursday, the energy sector proved to be a source of strength for the market. Leading the sector was strength from Halcon Resources Corp (NYSE: HK) and Bill Barrett Corporation (NYSE: BBG).

day trading penny stocks: PNC Financial Services Group, Inc. (The)(PNC)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Who is “the market” and how does it “want” to go down? Where’s the commandment that says stocks have to go lower? Who decides that today people who own stocks are by and large going to lose money? And why, of all things, does the market not want to go higher? Didn’t the CEO of the biggest bank, JPMorgan (JPM) , say things are great? Didn’t Wells Fargo (WFC) , after all of that scandal, still show some growth, a sign that it is putting the rough patch behind it? Didn’t Citigroup (C) have its best quarter in years? Wasn’t PNC Financial (PNC) even better, clear triumphs on every single line item? The word “perfect” comes to mind, as in Perfect National Corp. (Wells Fargo and Citigroup are part of TheStreet’s Action Alerts PLUS portfolio.)

  • [By Lisa Levin] Related WFC Why Bank ETFs Fell On Friday Despite Decent Earnings Phil's Stock World: Funtime Friday Earnings Season Starts Today Rising Book Values and Margins of Safety (GuruFocus)
    Related C Earnings Preview: Financial Giants BAC, GS, And MS Report Q2 Results This Week Why Bank ETFs Fell On Friday Despite Decent Earnings Palo Capital, Inc. Buys Citigroup Inc, Schlumberger, NetApp Inc, Sells Citrix Systems Inc, … (GuruFocus) Companies Reporting Before The Bell
    Wells Fargo & Co (NYSE: WFC) is estimated to report quarterly earnings at $1.02 per share on revenue of $22.51 billion.
    Citigroup Inc (NYSE: C) is projected to report quarterly earnings at $1.26 per share on revenue of $17.71 billion.
    JPMorgan Chase & Co. (NYSE: JPM) is expected to report quarterly earnings at $1.65 per share on revenue of $25.61 billion.
    PNC Financial Services Group Inc (NYSE: PNC) is projected to report quarterly earnings at $2.02 per share on revenue of $4.00 billion.
    First Republic Bank (NYSE: FRC) is estimated to report quarterly earnings at $1.1 per share on revenue of $675.70 million.
    First Horizon National Corp (NYSE: FHN) is projected to report quarterly earnings at $0.28 per share on revenue of $337.89 million.

     

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

day trading penny stocks: Silicom Ltd(SILC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Silicom Ltd. (NASDAQ: SILC) shares were also up, gaining 17 percent to $45.45. Silicom reported a major new design win with $17 million in purchase orders.

Top 10 Medical Stocks To Own For 2018

Shutterstock

If you have the choice between making a major purchase on a credit card or a personal loan, your first choice should be neither.

Your first choice – if you will not be able to pay back the purchase by the end of the month – should be cash. If you do not have the cash, then you should consider skipping the purchase until you have saved enough money.

Now, that may be easier said than done.

There may be important life milestones, medical necessities and other purchases that necessitate financing, given your personal financial circumstances and financial life goals.

While credit cards have many benefits and offer all types of rewards (cash back, travel and more), they are not always the best option – particularly for longer-term financing needs.

For these major purchases and life milestones – if sufficient cash is not readily available – a personal loan may be a less expensive option.

Top 10 Medical Stocks To Own For 2018: ONEOK Partners L.P.(OKS)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Energy infrastructure companies ONEOK (NYSE:OKE) and TransCanada (NYSE:TRP) are both emerging from the energy market downturn as stronger entities. Each made smart acquisitions, with TransCanada buying U.S. gas pipeline company Columbia Pipeline Group, while ONEOK is in the process of gobbling up its MLP,ONEOK Partners (NYSE:OKS). While these deals enhanced the growth profiles of both companies, TransCanada still stands out as the better buy for long-term income investors. Here’s why.

  • [By Garrett Cook]

    Citi maintains Buy ratings on Targa Resources (NYSE: TRGP), ONEOK (NYSE: OKE) and Oneok Partners (NYSE: OKS) citing the companies stories around natural gas liquids (NGLs).

Top 10 Medical Stocks To Own For 2018: Chesapeake Energy Corporation(CHK)

Advisors’ Opinion:

  • [By Paul Ausick]

    Chesapeake Energy Corp. (NYSE: CHK) traded up about 3.4% at $3.94 in a 52-week range of $3.41 to $8.20.

    EOG Resources Inc. (NYSE: EOG) traded up about 0.9% at $102.50. The 52-week range is $81.99 to $109.37.

  • [By WWW.KIPLINGER.COM]

    When it comes to energy stocks to watch, Chesapeake Energy Corporation (CHK) has to be on the top of the list.

    This past quarter, CHK continued on its transition plans to reduce its heavy debt load, remake its portfolio of assets and live to see another day. And it seemed at first, CHK was doing just that. The natural gas fracker, however, was hit by some pretty bad news at the end of the quarter.

  • [By Johanna Bennett]

    Yet again, Chesapeake Energy (CHK) has tumbled to the bottom of the S&P 500, delivering the biggest declines of the day despite a rise in natural gas prices.

    Chesapeake Energy dropped 4.2%, or 26 cents to $5.89, while the S&P 500 declined 0.68% to 2,328.95. Front Month Nymex natural gas for May delivery rose 1.35% to $3.230 per million British thermal units.

    Last month, Stifel Nicolaus analyst Karl Chalabala kicked off coverage of the natural-gas and oil-exploration company with a buy rating, saying the stock would give investors exposure to a bullish demand cycle. At $10, his price target suggested, at that time, that the stock could double over the next 12 months.

    Chesapeake has fallen more than 16% since the start of 2017

  • [By Paul Ausick]

    Chesapeake Energy Corp. (NYSE: CHK) posted a new 52-week low of $3.59 on Monday, down about 5.3% from Friday’s closing price of $3.79. The stock’s 52-week high is $8.20. Volume totaled around 36 million shares, about 1 million more than the daily average. The company acknowledged that its oil & gas production would be constrained as long as Harvey continues to keep refineries and terminals closed.

  • [By Matthew DiLallo]

    The high-end represents a robust growth rate for a company of its size. For perspective, the nation’s second-largest gas producer,Chesapeake Energy (NYSE:CHK), sees its output rising 5% to 15% annually through 2020. Meanwhile, smaller rival Antero Resources expects to grow 20% to 25% this year, while delivering 20% to 22% annual growth from 2018 to 2020. However, that is off a lower production base of roughly 657 billions of cubic feet equivalent compared to 870 billions of cubic feet equivalent for Southwestern.

  • [By Kumar Abhishek]

    Shares ofChesapeake Energy Corporation(NYSE:CHK) have been in a downtrend over the past three months, declining 25% in this period. In a bearish move,Chesapeake Energy Corporation’s 50-day and 200-day SMA’s formed a death cross afew days ago. A death cross is a strong bearish signal. However, the stock continued to climb up. Chesapeake Energy Corporation technical chart, the stock has broken out above the 20-day SMA which had provided strong resistance in the past. A breakout above the 20-day SMA resistance in spite of death cross suggests astrong bullish trend. The stock is now forming a double bottom pattern. The double bottom is a bullish trend reversal pattern, which indicates a medium term reversal in the trend. The double bottom patternwill be complete when the stock hits the previous high.

Top 10 Medical Stocks To Own For 2018: Accenture plc.(ACN)

Advisors’ Opinion:

  • [By Steve Symington]

    The stock market was mostly flat today ahead of a key House vote on the passage of the Republicans’ healthcare bill, which was delayed until Friday after GOP lawmakers failed to gather the necessary support. TheDow Jones Industrial Averagelost just 5 points, or 0.02%, while other broader market indexes saw similar small declines. But several individual stocks saw much more severe drops, including Zillow Group (NASDAQ:Z) (NASDAQ:ZG), Proofpoint (NASDAQ:PFPT), and Accenture (NYSE:ACN). Read on to see what drove these unusual moves.

  • [By Laurie Kulikowski]

    With a dividend payout ratio of 44% and dividend yield of 2%, we consider Accenture our favorite income oriented security, recognizing valuation is near peak multiples. Fundamentally, we believe its mix of business should result in above-average revenue growth, and mix allows for modest margin expansion (rare in IT Services), that should result in steady and attractive double-digit total returns to shareholders. 

  • [By Laurie Kulikowski]

    The company, on the basis of net income growth from the same quarter one year ago, has significantly underperformed compared to the IT Services industry average, but is greater than that of the S&P 500. The net income increased by 5.2% when compared to the same quarter one year prior, going from $701.02 million to $737.63 million.

     

  • [By Lisa Levin]

    In trading on Thursday, industrial shares fell by 0.08 percent. Meanwhile, top losers in the sector included Accenture Plc (NYSE: ACN), down 4 percent, and Manitex International Inc (NASDAQ: MNTX), down 4 percent.

Top 10 Medical Stocks To Own For 2018: Vermillion, Inc.(VRML)

Advisors’ Opinion:

  • [By Alex McGuire]

    Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…

    Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%

    The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.

Top 10 Medical Stocks To Own For 2018: Eagle Bulk Shipping Inc.(EGLE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Eagle Bulk Shipping Inc (NASDAQ: EGLE) were down 49 percent to $0.381. Eagle Bulk Shipping announced after Wednesday’s close it has reached an agreement with its lenders and holders of its equity to raise $105 million.

Top 10 Medical Stocks To Own For 2018: Blackrock Global(BOE)

Advisors’ Opinion:

  • [By Robert Rapier]

    Whiting Petroleum (WLL) is one of Continental’s biggest competitors in the Bakken. Whiting is the second-largest oil producer in North Dakota, averaging 82,500 barrels of oil equivalent (BOE) of production in 2012, across more than 700,000 acres of leased land.

Top 10 Medical Stocks To Own For 2018: Intellipharmaceutics International Inc.(IPCI)

Advisors’ Opinion:

  • [By Lisa Levin]

    IntelliPharmaCeutics Intl Inc (USA) (NASDAQ: IPCI) shares dropped 45 percent to $1.38 as the company disclosed that a FDA panel voted against approving the company’s NDA for Rexista™ abuse-deterrent oxycodone hydrochloride extended release tablets.

Top 10 Medical Stocks To Own For 2018: Nutraceutical International Corporation(NUTR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Monday. Top gainers in the sector included Nutraceutical Int'l Corp. (NASDAQ: NUTR), BRF SA (ADR) (NYSE: BRFS), and Chefs' Warehouse Inc (NASDAQ: CHEF).

Top 10 Medical Stocks To Own For 2018: Rubicon Technology, Inc.(RBCN)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap LED semiconductor stockRubicon Technology (NASDAQ: RBCN):

    Rubicon Technology isn’t going to be a monster-sized winner for us, even if things go perfectly. About the best downside target we could hope for is the $0.60 area, where the stock was launched into an unsustainable uptrend a week ago. But, it’s a high-odds trade we can’t pass up. Yesterday’s doji bar after a big rally was a warning sign that we were transitioning into a net-selling environment. Today’s sharp pullback confirms we’re moving into that bearish mode.

Top 10 Medical Stocks To Own For 2018: Enbridge Inc(ENB)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested shorting small cap energy transportation and distribution stock Enbridge Inc (NYSE: ENB):

  • [By Matthew DiLallo]

    Not to be outdone, rival Canadian oil pipeline giant Enbridge (NYSE:ENB) announced a transformational gas-focused deal of its own, agreeing to acquire U.S. pipeline company Spectra Energy (NYSE:SE) for $28 billion. That transaction will catapult Enbridge past TransCanada and create the largest energy infrastructure company in North America. Further, the deal will bolster Enbridge’s near-term capital project backlog to $20 billion, while enhancing its inventory of longer-term investment opportunities to $37 billion. This pipeline supports Enbridge’s view that it can increase its dividend by 10% to 12% annually through 2024.